Media center
Press release
Owkin launches ATLANTIS: An extensive multimodal patient data discovery program across 7 countries in 11 therapeutic areas
February 27, 2025
Press release
Owkin launches ATLANTIS: An extensive multimodal patient data discovery program across 7 countries in 11 therapeutic areas
February 27, 2025
Explore
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Press release
Owkin announces multi-year clinical data science strategic collaboration with Bristol Myers Squibb
June 7, 2022
Owkin announces multi-year clinical data science strategic collaboration with Bristol Myers Squibb
June 7, 2022
In the media
Investors are betting big on AI start-ups to accelerate drug development
June 2, 2022
Investors are betting big on AI start-ups to accelerate drug development
June 2, 2022
Financial Times
Press release
Owkin joins the Gaia-X European Association to contribute to a sustainable European data ecosystem
May 30, 2022
Owkin joins the Gaia-X European Association to contribute to a sustainable European data ecosystem
May 30, 2022
Press release
Owkin and ADC Therapeutics to build AI models to improve hematologic cancer treatment
April 27, 2022
Owkin and ADC Therapeutics to build AI models to improve hematologic cancer treatment
April 27, 2022
Press release
Owkin appoints Sanofi’s Global Head of Partnering Alban de La Sablière as Chief Business Officer
April 10, 2022
Owkin appoints Sanofi’s Global Head of Partnering Alban de La Sablière as Chief Business Officer
April 10, 2022
Press release
Owkin announces new Scientific Advisory Board chaired by world-leading precision oncologist
March 25, 2022
Owkin announces new Scientific Advisory Board chaired by world-leading precision oncologist
March 25, 2022
Press release
Fierce Medtech names Owkin a 'Fierce 15' Med Tech Company of 2021
March 7, 2022
Fierce Medtech names Owkin a 'Fierce 15' Med Tech Company of 2021
March 7, 2022
In the media
On BBC Radio 5 Live, Owkin co-founder and CEO Thomas Clozel explains our new AI project to better detect HER2-positive breast cancer
February 16, 2022
On BBC Radio 5 Live, Owkin co-founder and CEO Thomas Clozel explains our new AI project to better detect HER2-positive breast cancer
February 16, 2022
In the media
How AI is helping to treat HER2-low breast cancer patients
January 20, 2022
How AI is helping to treat HER2-low breast cancer patients
January 20, 2022
The Times
In the media
Owkin collaborates with UK hospitals to turbocharge AI breast cancer diagnosis
January 19, 2022
Owkin collaborates with UK hospitals to turbocharge AI breast cancer diagnosis
January 19, 2022